Since Broomfield et al. first demonstrated the BChE neuroprotective function against neurotoxic agents in 1991, it has garnered substantial attention within the scientific community.25 Its pivotal role in neurodegenerative disorders, especially Alzheimer's disease (AD), has emerged as a focal point of research. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.